lncRNA MIRF Promotes Cardiac Apoptosis through the miR-26a-Bak1 Axis

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• RNA Biology

Background:

• Acute myocardial infarction (AMI) is a primary global cause of mortality.
• Therapeutic strategies for ischemic heart disease focus on inhibiting cardiac cell death.
• The role of MIRF-miR-26a interactions in AMI-induced apoptosis requires elucidation.

Purpose of the Study:

• To investigate the function of MIRF and miR-26a in cardiomyocyte apoptosis during AMI.
• To determine the molecular mechanisms underlying MIRF-mediated regulation of miR-26a in cardiac injury.
• To assess the therapeutic potential of targeting the MIRF-miR-26a axis for ischemic heart disease.

Main Methods:

• Analysis of miR-26a expression in MI mice hearts and H2O2-treated cardiomyocytes.
• In vitro and in vivo experiments involving miR-26a silencing and overexpression.
• Assessment of apoptosis, mitochondrial ATP content, and mitochondrial membrane potential (MMP).
• Investigation of Bak1 as a downstream target of miR-26a.

Main Results:

• miR-26a was downregulated in MI hearts and cardiomyocytes exposed to H2O2.
• miR-26a overexpression attenuated H2O2-induced apoptosis, increased ATP content and MMP.
• miR-26a inhibited apoptosis by regulating Bak1.
• MIRF promoted apoptosis by decreasing ATP and MMP via miR-26a, an effect reversed by MIRF deficiency or miR-26a inhibition.

Conclusions:

• MIRF exacerbates cardiomyocyte apoptosis in AMI by downregulating miR-26a and modulating Bak1.
• Restoration of miR-26a function offers a potential therapeutic strategy for ischemic heart disease.
• The MIRF-miR-26a pathway represents a novel target for treating myocardial infarction.